692 related articles for article (PubMed ID: 9128983)
1. Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma.
Ravindranath MH; Amiri AA; Bauer PM; Kelley MC; Essner R; Morton DL
Cancer; 1997 May; 79(9):1686-97. PubMed ID: 9128983
[TBL] [Abstract][Full Text] [Related]
2. Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.
Ravindranath MH; Kelley MC; Jones RC; Amiri AA; Bauer PM; Morton DL
Int J Cancer; 1998 Jan; 75(1):117-24. PubMed ID: 9426699
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
Ragupathi G; Damani P; Srivastava G; Srivastava O; Sucheck SJ; Ichikawa Y; Livingston PO
Cancer Immunol Immunother; 2009 Sep; 58(9):1397-405. PubMed ID: 19190907
[TBL] [Abstract][Full Text] [Related]
4. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium.
Fujii Y; Yoshida M; Chien LJ; Kihara K; Kageyama Y; Yasukochi Y; Oshima H
Urol Int; 2000; 64(3):129-33. PubMed ID: 10859542
[TBL] [Abstract][Full Text] [Related]
5. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma.
Renkonen J; Paavonen T; Renkonen R
Int J Cancer; 1997 Jun; 74(3):296-300. PubMed ID: 9221808
[TBL] [Abstract][Full Text] [Related]
6. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Chu KU; Ravindranath MH; Gonzales A; Nishimoto K; Tam WY; Soh D; Bilchik A; Katopodis N; Morton DL
Cancer; 2000 Apr; 88(8):1828-36. PubMed ID: 10760759
[TBL] [Abstract][Full Text] [Related]
8. E-selectin: sialyl Lewis, a dependent adhesion of colon cancer cells, is inhibited differently by antibodies against E-selectin ligands.
Srinivas U; Påhlsson P; Lundblad A
Scand J Immunol; 1996 Sep; 44(3):197-203. PubMed ID: 8795712
[TBL] [Abstract][Full Text] [Related]
9. Sialyl-Lewis(x/a)-decorated selectin ligands in head and neck tumours.
Renkonen J; Mäkitie A; Paavonen T; Renkonen R
J Cancer Res Clin Oncol; 1999 Oct; 125(10):569-76. PubMed ID: 10473870
[TBL] [Abstract][Full Text] [Related]
10. Novel monoclonal antibodies to putative selectin carbohydrate ligands that inhibit selectin binding to myeloid cells.
Zhang K; Chuluyan HE; Hardie D; Shen DC; Larsen R; Issekutz A
Hybridoma; 1998 Oct; 17(5):445-56. PubMed ID: 9873990
[TBL] [Abstract][Full Text] [Related]
11. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions.
Liang S; Dong C
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C701-7. PubMed ID: 18632734
[TBL] [Abstract][Full Text] [Related]
12. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells.
Kobzdej MM; Leppänen A; Ramachandran V; Cummings RD; McEver RP
Blood; 2002 Dec; 100(13):4485-94. PubMed ID: 12393554
[TBL] [Abstract][Full Text] [Related]
13. Detection of ligands for selectins in the oligosaccharide fraction of human milk.
Rudloff S; Stefan C; Pohlentz G; Kunz C
Eur J Nutr; 2002 Apr; 41(2):85-92. PubMed ID: 12083318
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells.
Martín-Satué M; Marrugat R; Cancelas JA; Blanco J
Cancer Res; 1998 Apr; 58(7):1544-50. PubMed ID: 9537262
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA.
Ravindranath MH; Bauer PM; Cornillez-Ty C; Garcia J; Morton DL
J Immunol Methods; 1996 Oct; 197(1-2):51-67. PubMed ID: 8890894
[TBL] [Abstract][Full Text] [Related]
16. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
[TBL] [Abstract][Full Text] [Related]
17. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
Hoon DS; Yuzuki D; Hayashida M; Morton DL
J Immunol; 1995 Jan; 154(2):730-7. PubMed ID: 7814879
[TBL] [Abstract][Full Text] [Related]
18. Selectin ligands on human melanoma cells.
Miller N; Vile RG; Hart IR
Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
[TBL] [Abstract][Full Text] [Related]
19. Differences between human eosinophils and neutrophils in the function and expression of sialic acid-containing counterligands for E-selectin.
Bochner BS; Sterbinsky SA; Bickel CA; Werfel S; Wein M; Newman W
J Immunol; 1994 Jan; 152(2):774-82. PubMed ID: 7506734
[TBL] [Abstract][Full Text] [Related]
20. In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.
Renkonen R; Mattila P; Majuri ML; Räbinä J; Toppila S; Renkonen J; Hirvas L; Niittymäki J; Turunen JP; Renkonen O; Paavonen T
Glycoconj J; 1997 Aug; 14(5):593-600. PubMed ID: 9298692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
